AI Engines For more Details: Perplexity Kagi Labs You
Heart Health: Cacao flavonoids have been shown to have beneficial effects on heart health. They help improve endothelial function, which is essential for maintaining healthy blood vessels and regulating blood flow. Flavanols also have antioxidant properties, helping to reduce oxidative stress and inflammation in the cardiovascular system. Regular consumption of cacao flavonoids may contribute to lower blood pressure, improved blood vessel function, and reduced risk of cardiovascular diseases such as heart disease and stroke.
Blood Pressure Regulation: Flavanols found in cacao have been associated with the ability to lower blood pressure. They help relax blood vessels, improve blood flow, and promote the release of nitric oxide, a compound that dilates blood vessels. By reducing peripheral resistance in the blood vessels, cacao flavonoids may contribute to lower systolic and diastolic blood pressure, potentially reducing the risk of hypertension and its associated complications.
Antioxidant Activity: Cacao flavonoids are potent antioxidants that help neutralize harmful free radicals in the body, reducing oxidative stress and cellular damage. By scavenging free radicals and inhibiting oxidative processes, flavonoids protect cells and tissues from oxidative damage and inflammation. This antioxidant activity may help prevent chronic diseases such as cancer, neurodegenerative disorders, and cardiovascular diseases, as well as slow down the aging process.
Cognitive Function: Flavanols found in cacao have been studied for their potential effects on cognitive function and brain health. They help improve cerebral blood flow, stimulate neurogenesis (the formation of new neurons), and enhance synaptic plasticity, all of which contribute to better cognitive performance and memory. Regular consumption of cacao flavonoids may help support cognitive function, enhance learning and memory, and reduce the risk of age-related cognitive decline and neurodegenerative diseases such as Alzheimer's disease.
Skin Health: Cacao flavonoids have been shown to have beneficial effects on skin health. They help protect against UV-induced damage, reduce inflammation, and promote collagen synthesis, leading to improved skin hydration, elasticity, and appearance. Consuming cacao flavonoids or applying cacao-based skincare products may help protect against sunburn, premature aging, and skin disorders such as eczema and psoriasis.
Exercise Performance: Cacao flavonoids, particularly theobromine and caffeine, have stimulant properties that may help improve exercise performance and endurance. They enhance alertness, energy levels, and oxygen utilization during physical activity, leading to better athletic performance and recovery. Consuming dark chocolate or cocoa products containing flavonoids before exercise may help boost energy, delay fatigue, and enhance exercise capacity.
| Rank | Probiotic | Impact |
|---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| ADHD | 0.3 | -0.3 | |
| Alzheimer's disease | 0.6 | 0.6 | |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.3 | 0.3 | |
| Ankylosing spondylitis | 0.3 | 0.6 | -1 |
| Asthma | 0.3 | -0.3 | |
| Atrial fibrillation | 0.6 | -0.6 | |
| Autism | 0.9 | 0.9 | 0 |
| Barrett esophagus cancer | 0.3 | 0.6 | -1 |
| Bipolar Disorder | 0.6 | 0.6 | |
| Celiac Disease | 0.6 | 0.6 | 0 |
| Cerebral Palsy | 0.6 | -0.6 | |
| Chronic Fatigue Syndrome | 0.6 | 0.6 | 0 |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.6 | -0.6 | |
| Chronic Urticaria (Hives) | 0.6 | -0.6 | |
| Coronary artery disease | 0.6 | 0.6 | |
| COVID-19 | 0.2 | 0.6 | -2 |
| Crohn's Disease | 0.6 | -0.6 | |
| Depression | 0.9 | 0.9 | |
| Eczema | 0.3 | 0.6 | -1 |
| Endometriosis | 0.6 | 0.6 | |
| Eosinophilic Esophagitis | 0.6 | 0.6 | |
| gallstone disease (gsd) | 0.6 | -0.6 | |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.6 | -0.6 | |
| Graves' disease | 0.3 | 0.3 | |
| Halitosis | 0.6 | -0.6 | |
| Hidradenitis Suppurativa | 0.6 | 0.6 | |
| Inflammatory Bowel Disease | 0.2 | -0.2 | |
| Intelligence | 0.2 | -0.2 | |
| Irritable Bowel Syndrome | 0.6 | 0.6 | 0 |
| Liver Cirrhosis | 0.6 | 0.6 | 0 |
| Long COVID | 0.3 | 0.9 | -2 |
| Menopause | 0.2 | -0.2 | |
| Metabolic Syndrome | 0.3 | -0.3 | |
| Mood Disorders | 0.9 | 0.2 | 3.5 |
| multiple chemical sensitivity [MCS] | 0.6 | -0.6 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.3 | -0.3 | |
| Obesity | 0.2 | -0.2 | |
| obsessive-compulsive disorder | 0.6 | -0.6 | |
| Osteoporosis | 0.6 | -0.6 | |
| Parkinson's Disease | 0.6 | 0.6 | |
| primary biliary cholangitis | 0.3 | -0.3 | |
| Psoriasis | 0.9 | -0.9 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.6 | 0.3 | 1 |
| Schizophrenia | 0.3 | 0.2 | 0.5 |
| Sjögren syndrome | 1 | -1 | |
| Sleep Apnea | 0.3 | -0.3 | |
| Systemic Lupus Erythematosus | 0.6 | -0.6 | |
| Type 1 Diabetes | 0.6 | -0.6 | |
| Type 2 Diabetes | 0.3 | -0.3 | |
| Unhealthy Ageing | 0.6 | -0.6 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.